Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/06/2003EP1331931A2 Treatment of tinnitus
08/06/2003EP1331929A1 Transdermal drug delivery system with improved water absorbability and adhesion properties
08/06/2003EP1331928A2 Particle formation methods and their products
08/06/2003EP1331927A1 Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid
08/06/2003EP1331926A2 Fast-acting antimicrobial lotion with enhanced efficacy
08/06/2003EP1331925A2 Use of an association of at least a carotenoid and of at least an isoflavonoid for treating cutaneous symptoms of ageing
08/06/2003EP1331924A2 Use of carotenoids for treating ageing symptoms
08/06/2003EP1331923A2 Use of the association of at least an plant extract of genus rosmarinus and of at least a carotenoid
08/06/2003EP1331919A2 Dental composition for hypersensitive teeth
08/06/2003EP1331902A2 Improved ophthalmic and contact lens solutions containing forms of vitamin b
08/06/2003EP1331858A2 Synergistic antioxidant combination of delta tocols and polyphenols
08/06/2003EP1331855A2 Aged companion pet diet
08/06/2003EP1289364A4 Stable gabapentin containing more than 2o ppm of chlorine ion
08/06/2003EP1244498B1 Combination of trimebutine with an opioid analgesic
08/06/2003EP1212345B1 Orally active 7-alpha-alkyl androgens
08/06/2003EP1207865B1 Composition for treatment of infections of humans and animals
08/06/2003EP1200070B1 Ambroxol-containing lozenge
08/06/2003EP1187838B1 Thiazolopyrimidines useful as TNF-Alpha inhibitors
08/06/2003EP1176149B1 Novel gymnemic acid derivatives, process for the preparation thereof and use thereof as medicine
08/06/2003EP1173187B1 Combined preparations comprising morpholine anthracyclines and platinum derivatives
08/06/2003EP1165544B1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
08/06/2003EP1162945B1 Particle based vaccine composition
08/06/2003EP1126846B1 Use of a nicotine receptor agonist for the manufacture of a medicament for the treatment of obsessive compulsive disorder
08/06/2003EP1117648B1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors
08/06/2003EP1117440B1 Pharmaceutical compositions containing paclitaxel
08/06/2003EP1109811B1 Pyrrolobenzodiazepines
08/06/2003EP1105102B8 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt
08/06/2003EP1098664B1 Conjugates for treating inflammatory disorders and associated tissue damage
08/06/2003EP1090022B1 2-(purin-9-yl)-tetrahydrofuran-3,4-diol derivatives
08/06/2003EP1084103B1 New 3-aryl-2-hydroxypropionic acid derivative (i)
08/06/2003EP1077684B1 Effervescent preparations
08/06/2003EP1069896B1 Carvedilol-galenics
08/06/2003EP1066027B1 Pharmaceutical composition of topiramate
08/06/2003EP1052963A4 Compositions and methods of treating keratin-related disorders and conditions
08/06/2003EP1032374B1 Spheroids, preparation method and pharmaceutical compositions
08/06/2003EP1005328B1 Composition comprising finely divided, crystalline particles of budesonide
08/06/2003EP0994890B1 Benzimidazole derivatives
08/06/2003EP0983064B1 PYRROLES AS sPLA2 INHIBITORS
08/06/2003EP0980381B1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders
08/06/2003EP0973499B1 Diffusional implantable delivery system
08/06/2003EP0946538B1 Indane or dihydroindole derivatives
08/06/2003EP0934321B1 Thienopyrimidine with phosphodiesterase v inhibiting effect
08/06/2003EP0918747B1 INHIBITORS OF THE PRODUCTION OF s-CD23 AND THE SECRETION OF TNF
08/06/2003EP0906086B1 Skin wash composition
08/06/2003EP0874800B1 Indane dimer compounds with smooth muscle relaxing and/or mast cell stabilising and/or antiinflammatory activity
08/06/2003EP0865419B1 Indane dimer compounds and their pharmaceutical use
08/06/2003EP0824353A4 Methods to inhibit acute radiation-induced skin damage
08/06/2003EP0824350B1 Use of an antifungal composition
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0806949B1 New pharmaceutical composition containing trimebutine and preparation process
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003EP0799209B1 Sulfonamides
08/06/2003EP0701449B1 Process for the preparation of an oral solid dosage form containing diclofenac
08/06/2003EP0695305B1 Method of forming oligonucleotides
08/06/2003EP0690718B1 Peritoneal dialysis solutions containing maltodextrins and amino acids
08/06/2003CN1434865A Regulation effect of conjugated frame transport protein ABC1
08/06/2003CN1434830A 2-aminocarbonyl-9H-punine derivatives
08/06/2003CN1434829A Processes for preparing clarithromycin polymorphs and novel polymorph IV
08/06/2003CN1434828A Novel bisamidate phosphonate prodrugs
08/06/2003CN1434827A 新的哌啶和哌嗪衍生物 The new piperidine and piperazine derivatives
08/06/2003CN1434825A Novel imidazo ÒÇö1,3,5ÒÇòtriazinones and the use thereof
08/06/2003CN1434824A Bicyclic inhibitors of glycogen synthase kinase 3
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434820A Cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434819A 4-phenyl-peiperazinyl,-piperidinyl and -Tetrahydropyridyl derivatives
08/06/2003CN1434818A Novel compounds
08/06/2003CN1434817A Pyrazole cyclic AMP-specific PDE inhibitors
08/06/2003CN1434816A Novel compounds
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434810A Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
08/06/2003CN1434808A Novel branched substituted amino derivatives of 3-amino-1-phemyl-1HÒÇö1,2,4ÒÇò triazo, methods for producing them and pharmaceutica compositions containing them
08/06/2003CN1434807A Pyrazine based inhibitors of glycogen synthase kinase 3
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434805A 选择性神经激肽拮抗剂 Selective neurokinin antagonists
08/06/2003CN1434803A Cyclic lactams as inhibitors os A-alpha protein production
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1434799A Cyclic amp-specific phosphodiesterase inhibitors
08/06/2003CN1434798A Pyrrolidines which inhibit CAMP-specific PDE
08/06/2003CN1434797A Hydrazone and oxime derivatives of pyrrolidine as AMP-specific phosphodiesterase inhibitons
08/06/2003CN1434796A Acylphenylurea derivatives, a process for their preparation and their use as pharmaceuticals
08/06/2003CN1434795A Acyl pseudodipeptides which carry a functionalised auxiliary arm
08/06/2003CN1434794A Adamantane derivatives
08/06/2003CN1434792A Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
08/06/2003CN1434727A Anglogenesis and vascular permeability modulators and inhibitors
08/06/2003CN1434726A Multivalent platform molecules comprising high molecular weight polyethylene oxide
08/06/2003CN1434725A Amphiphilic polymers and polypeptide conjugates comprising same
08/06/2003CN1434724A Remedies and/or preventives for nervous system disorders
08/06/2003CN1434723A Immunostimulatory oligodeoxynucleotides
08/06/2003CN1434722A Use of il-18 inhibitors for the treatment and/or prevention of atherosclerosis
08/06/2003CN1434719A Preparation capable of mobilization of activity
08/06/2003CN1434718A Activation and inhibition of immune system
08/06/2003CN1434715A Pharmaceutical compositions
08/06/2003CN1434714A Method and composition for the treatment of pain
08/06/2003CN1434713A Sustained-release formulation of a cyclooxygenase-2 inhibitor
08/06/2003CN1434712A Nitrosated and nitrosylated cyclooxygenase-2 inhibitors compositions and methods of use
1 ... 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 5400 5401 5402 5403 5404 5405 ... 7860